Cardiovascular Events After COVID-19 Vaccination: A Comment

References (1)

1. Jargin SV. COVID-19 Vaccination with special reference to ade- noviral vectors, clotting disorders and old age. J Geriatr Palliat Care. 2021;7(1):2. [CrossRef] 2. Petersen E, Koopmans M, Go U, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238-e244. [CrossRef] 3. Kircheis R. Coagulopathies after vaccination against SARS- CoV-2 may be derived from a combined effect of SARS-CoV-2 spike protein and adenovirus vector-triggered signaling path- ways. Int J Mol Sci. 2021;22(19):10791. [CrossRef] 4. Joob B, Wiwanitkit V. Acute myocarditis after coronavirus dis- ease 2019 vaccination. Anatol J Cardiol. 2021;25(11):841-842. [CrossRef] 5. Istampoulouoglou I, Dimitriou G, Späni S, et al. Myocarditis and pericarditis in association with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob Cardiol Sci Pract. 2021;2021(3):e202118. [CrossRef] 6. Greer SL, King EJ, Massard da Fonseca E, Peralta-Santos A. Coronavirus Politics: the Comparative Politics and Policy of COVID-19. Ann-Arbor: University of Michigan Press; 2021. 7. Denisenko AS, Riess ME, Kropachev IG, Nikitina NN. First cases of coagulation disorders as complications after the Gam- COVID-Vac (Sputnik V) vaccine. Vestn NovSU Med Sci. 2021;3(124):61-64. [CrossRef] 8. Independent Medical Association. Available at: http://expert- doctors.site/. 9. Cereda A, Conca C, Barbieri L, et al. Acute myocarditis after the second dose of SARS-CoV-2 vaccine: serendipity or atypical causal relationship? Anatol J Cardiol. 2021;25(7):522-523. [CrossRef